Cathie Wood’s ARK Invest Sells Over 60,000 Shares of Pluristem Therapeutics

One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 62,000 shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI) on Tuesday, as the share price of this fund traded up less than 1% in the day’s session. That share price has greatly improved over the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 62,738 shares of Pluristem. At Tuesday’s closing price, this would have valued this sale at roughly $252,000. This is only a small fraction of the total holdings. This fund is up 84% over the past 52 weeks.

Here is a quick look at all the other sales that took place across all ARK ETFs:

ARKGCSTLCastle Biosciences4,800
ARKGPSTIPluristem Therapeutics62,738
ARKQGLEOGalileo Acquisition1,798
ARKQRAVNRaven Industries8,104

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

ALSO READ: Top Market Strategist Says a Vicious 10% Correction Very Possible by November

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Source: Read Full Article